Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men

European Journal of Endocrinology

Volumn 150, Issue 2, 2004, Pages 185-194

  Johnstone, Alexandra M ^a   Faber, Peter ^a   Andrew, Ruth ^b   Gibney, Eileen R ^c   Elia, Marinos ^d   Lobley, Gerald ^a   Stubbs, R James ^a   Walker, Brian R ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; FAT; HYDROCORTISONE; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIETARY INTAKE; FEEDING; GAS CHROMATOGRAPHY; HORMONAL REGULATION; HORMONE ACTION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; INDWELLING CATHETER; LIVER REGENERATION; LOW CALORY DIET; MALE; MASS SPECTROMETRY; NEUROENDOCRINE SYSTEM; OBESITY; PRIORITY JOURNAL; STARVATION; STRESS; SUBCUTANEOUS TISSUE; TIME; UPREGULATION; URINALYSIS; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; CALORIC RESTRICTION; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OBESITY; STARVATION; WEIGHT LOSS;

EID: 1542300306     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500185     Document Type: Article

References (55)

1. Bjorntorp P. Endocrine abnormalities in obesity. Diabetes Reviews 1997 5 52-68.
2. Marin P, Darin M, Amemiya T, Andersson B, Jern S & Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese pre-menopausal women. Metabolism 1992 4 1882-1886.
3. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. Journal of Clinical Endocrinology and Metabolism 1993 77 341-346.
4. Rosmond R, Dallman MF & Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. Journal of Clinical Endocrinology and Metabolism 1998 83 1853-1859.
5. Ljung T, Andersson B, Bengtsson B, Bjorntorp P & Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Research 1996 4 277-282.
6. Walker BR, Soderberg S, Lindahl B & Olsson T. Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. Journal of Internal Medicine 2000 247 198-204.
7. Strain GW, Zumoff B & Strain JJ. Cortisol production in obesity. Metabolism: Clinical and Experimental 1980 29 980-985.
8. Lottenberg SA, Giannella-Neto D, Derendorf H, Rocha M, Bosco A, Carvalho SV et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity. International Journal of Clinical Pharmacology and Therapeutics 1998 36 501-505.
9. Andrew R, Phillips DIW & Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 1998 83 1806-1809.
10. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E & Connell JMC. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999 33 1364-1368.
11. Stewart PM, Shackleton CHL, Beastall GH & Edwards CRW. 5alpha-reductase activity in polycystic ovarian syndrome. Lancet 1990 335 431-433.
12. Stewart PM & Krozowski ZS. 11Beta hydroxysteroid dehydrogenase. Vitamins and Hormones 1999 57 249-324.
13. Seckl JR & Walker BR. 11β-Hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001 142 1371-1376.
14. Kotelevtsev YV, Holmes MC, Burchell A, Houston PM, Scholl D, Jamieson PM et al. 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. PNAS 1997 94 14924-14929.
15. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. Journal of Biological Chemistry 2001 276 41293-41300.
16. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001 294 2166-2170.
17. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DEW, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism 2001 86 1418-1421.
18. Lindsay RS, Tataranni A, Permana P, Livingstone DEW, Wake DJ & Walker BR. Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and mRNA levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism 2003 88 2738-2744.
19. Rask E, Walker BR, Soderberg S, Livingstone DEW, Eliasson M, Johnson O et al. Tissue-specific changes in peripheral cortisol metabolism in obese women increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism 2002 87 3330-3336.
20. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi M-C & Grino M. Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. Journal of Clinical Endocrinology and Metabolism 2002 87 2701-2705.
21. Stewart PM, Boulton A, Kumar S, Clark PMS & Shackleton CHL. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. Journal of Clinical Endocrinology and Metabolism 1999 84 1022-1027.
22. Walker BR, Connacher AA, Lindsay RM, Webb DJ & Edwards CRW. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism 1995 80 3155-3159.
23. Bujalska IJ, Kumar S & Stewart PM. Does central obesity reflect 'Cushing's disease of the omentum? Lancet 1997 349 1210-1213.
24. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C et al. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002 45 1528-1532.
25. Andrews RC, Rooyackers O & Walker BR. Effects of the 11beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2003 88 285-291.
26. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ & Walker BR. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000 141 560-563.
27. Livingstone DEW, Kenyon CJ & Walker BR. Mechanisms of dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in Zucker obese rats. Journal of Endocrinology 2000 167 533-539.
28. Stubbs RJ, O'Reilly LM, Johnstone AM, Franklin MF & Reid C. Description and evaluation of an experimental model to examine changes in qualitative and quantitative feeding behaviour in humans. European Journal of Clinical Nutrition 1999 53 13-21.
29. Black AE, Coward WA, Cole TJ & Prentice AM. Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements. European Journal of Clinical Nutrition 1996 50 72-92.
30. Spurr GB, Prentice AM, Murgatroyd PR, Goldberg GR, Reina JC & Christman NT. Energy expenditure from minute-by-minute heart-rate recording: comparison with indirect calorimetry American Journal of Clinical Nutrition 1988 48 552-559.
31. Ceesay SM, Prentice AM, Day KC, Murgatroyd PR, Goldberg GR & Scott W. The use of heart rate monitoring in the estimation of energy expenditure: a validation study using indirect whole body calorimetry. British Journal of Nutrition 1989 71 175-186.
32. Fuller NJ, Jebb SA, Laskey MA, Coward WA & Elia M. Four-compartment model for the assessment of body composition in humans: comparison with alternative methods and evaluation of the density and hydration of fat-free mass. Clinical Science 1992 82 687-693.
33. Pullicino E, Coward WA, Stubbs RJ & Elia M. Bedside and field methods for assessing body composition: comparison with the deuterium dilution technique. European Journal of Clinical Investigation 1990 40 753-762.
34. McConway MG & Chapman RS. Development and evaluation of a simple, direct, solid-phase radioimmunoassay of serum cortisol from readily available reagents. Clinica Chimica Acta 1986 158 59-70.
35. Best R & Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clinical Endocrinology 1997 47 231-236.
36. Zumoff B, Fukushima DK & Hellman L. Intercomparison of four methods for measuring cortisol production. Journal of Clinical Endocrinology and Metabolism 1974 38 169-175.
37. Ulick S, Tedde R & Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism 1992 74 593-599.
38. Palermo M, Shackleton CHL, Mantero F & Stewart PM. Urinary free cortisone and the assessment of 11beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology 1996 45 605-611.
39. Fichter MM, Pirke K-M & Holsboer F. Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects. Psychiatry Research 1986 17 61-72.
40. Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PW & Chrousos GP. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. Journal of Clinical Endocrinology and Metabolism 1993 76 675-679.
41. Wabitsch M, Hauner H, Heinze E, Bockmann A, Benz R, Mayer H et al. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. Journal of Clinical Endocrinology and Metabolism 1995 80 3469-3475.
42. Hainer V, Stich V, Kunesova M, Parizkova J, Zak A & Wernischova V. Effect of 4-wk treatment of obesity by very-low-calorie diet on anthropometric, metabolic, and hormonal indexes. American Journal of Clinical Nutrition 1992 56 281S-282S.
43. Haluzik M, Matoulek M, Svacina S, Hilgertova J & Haas T. The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocrine Research 2001 27 251-260.
44. Fraser DA, Thoen J, Selvaag A-M, Djoseland O, Forre O & Kjeldsen-Kragh J. A preliminary study of circadian serum cortisol concentrations in response to a 72-hour fast in rheumatoid arthritis patients not previously treated with corticosteroids. Clinical Rheumatology 2001 20 85-87.
45. Bernier J, Jobin N, Emptoz-Bonneton A, Pugeat MM & Garrel DR. Decreased corticosteroid-binding globulin in burn patients: relationship with interleukin-6 and fat in nutritional support. Critical Care Medicine 1998 26 452-460.
46. Anderson KE, Rosner W & Khan MS. Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man. Life Sciences 1987 40 1761-1768.
47. Kaye TB & Crapo L. The Cushing syndrome: an update on diagnostic tests. Annals of Internal Medicine 1990 112 434-444.
48. Andrew R, Smith K, Jones GC & Walker BR. Use of multideuterated cortisol to distinguish activities of 11β-hydroxysteroid dehydrogenases in vivo in man. Journal of Clinical Endocrinology and Metabolism 2002 87 277-285.
49. Imperato-McGinley J, Shackleton C, Orlic S & Stoner E. C19 and C21 5beta/5alpha metabolite ratios in subjects treated with the 5alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5alpha-reductase deficiency. Journal of Clinical Endocrinology and Metabolism 1990 70 777-782.
50. Pratis K, O'Donnell L, Ooi GT, Stanton PG, McLachlan RI & Robertson DM. Differential regulation of rat testicular 5α-reductase type 1 and 2 isoforms by testosterone and FSH. Journal of Endocrinology 2003 176 393-403.
51. Matsui D, Sakari M, Sato T, Murayama A, Takada I, Kim M et al. Transcriptional regulation of the mouse steroid 5α-reductase type II gene by progesterone in brain. Nucleic Acids Research 2002 30 1387-1393.
52. Ulick S, Wang JZ, Blumenfeld JD & Pickering TG. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism 1992 74 963-967.
53. Walker BR, Campbell JC, Fraser R, Stewart PM & Edwards CRW. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome, Clinical Endocrinology 1992 27 483-492.
54. Phillipou G. Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome. Clinical Endocrinology 1982 16 433-439.
55. Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. Journal of Clinical Endocrinology and Metabolism 1989 68 173-179.